Appendix  4C    Quarterly  report  for  entities     admitted  on  the  basis  of  commitments  

Rule  4.7B  

Appendix 4C Quarterly report for entities admitted on the basis of commitments

Introduced  31/03/00    Amended  30/09/01,  24/10/05,  17/12/10  

Name  of  entity  

ALEXIUM  INTERNATIONAL  GROUP  LIMITED  

ABN  

Quarter  ended  ("current  quarter")  

91  064  820  408  

31  December  2011  

Consolidated  statement  of  cash  flows

Cash  flows  related  to  operating  activities  

1.1   Receipts  from  customers  

1.2   Payments  for   (a)    staff  costs  

(b)  advertising  &  marketing  

(c)  research  &  development  

(d)    leased  assets  

(e)    other  working  capital  

1.3   Dividends  received  

1.4   Interest   and   other   items   of   a   similar   nature  

received  

1.5   Interest  and  other  costs  of  finance  paid  

1.6   Income  taxes  paid  

1.7   Other  (GST)  

Net  operating  cash  flows


+  See  chapter  19  for  defined  terms.  

17/12/2010     Appendix  4C  Page  1  

Appendix  4C     Quarterly  report  for  entities     admitted  on  the  basis  of  commitments  

Current  quarter  

$A'000  

Year  to  date  (...6....months)    

$A'000  

1.8   Net  operating  cash  flows  (carried  forward)  

(405)  

(1,041)  

Cash  flows  related  to  investing  activities  

1.9   Payment  for  acquisition  of:    (a)    businesses  (item  5)    

(b)    equity  investments  

(c)    intellectual  property  

(d)    physical  non-­

© Publicnow - 2012
Alexium International Group Limited Appoints T. Randall Lane as Director CI
Alexium International Group Limited Appoints Martyn Strickland as Director CI
Transcript : Alexium International Group Limited - Special Call
Alexium International Group Completes Entitlement Offer MT
Transcript : Alexium International Group Limited, Q3 2024 Earnings Call, Apr 26, 2024
Transcript : Alexium International Group Limited - Shareholder/Analyst Call
Transcript : Alexium International Group Limited, H1 2024 Earnings Call, Mar 15, 2024
Alexium International Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Alexium International Group Confirms Capital Structure MT
Alexium International Group Refinances Debt, Raises Capital to Support Growth Plans; Shares Up 15% MT
Alexium International CFO Resigns Earlier than Anticipated MT
Alexium International Group Chair Resigns MT
Alexium International Group Limited Announces Board Changes CI
Alexium International Group Limited Announces Resignation of Stephen Cheney as Non-Executive Director, Effective 1 November 2023 CI
Alexium CFO Steps Down; Shares Rise 6% MT
Alexium International Group Limited Announces Resignation of Jason Lewis as Chief Financial Officer CI
Transcript : Alexium International Group Limited, 2023 Earnings Call, Aug 31, 2023
Alexium International Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Alexium International Launches Heat Regulating Pillow Liner Product; Shares Rise 6% MT
Alexium International Group Limited Announces Launch of its New Dehumidification Technology, DelCool, in the Top-Of-Bed Market Segment CI
Transcript : Alexium International Group Limited, Q2 2023 Earnings Call, Mar 16, 2023
Alexium International Group Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Alexium International Secures Convertible Bond Extension; Shares Fall 6% MT
Alexium International Group Limited Appoints William Timothy Blackburn as Director CI
Alexium International Group Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Chart Alexium International Group Limited
More charts
Alexium International Group Limited is an Australia-based performance chemicals provider for advanced materials applications with a focus on flame retardancy and thermal management. The Company’s principal activities include research and development in consultation with end clients; obtaining patents in relation to new products developed; and commercialization and sales of the products. The Company’s product solutions include thermal regulation solutions and flame-retardant solutions. Its thermal regulation solutions include Alexicool, BioCool, Eclipsys and DelCool. Alexicool is a phase change material (PCM)-based cooling product for textile and foam applications. BioCool is a biobased microencapsulated PCM (mPCM) line of products for the bedding industry. Eclipsys is a perpetual cooling technology for textile and foam-based products. Its flame-retardant solution includes Alexiflam and Alexiguard. The Alexiflam is a flame-retardant technology for use in mattress applications.
More about the company
Best financial portal

Best financial
portal

+951% of historicalperformance

+951% of historical
performance

More than 20 yearsat your side

More than 20 years
at your side

Google
Trustpilot
+     
                    
    10,00,000
members

+ 10,00,000
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-12pm / 2pm-6pm GMT + 1

Contact us
MarketScreener, Stock Market Live